Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Acyclic Nucleosides. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107827890A reveals dynamic kinetic resolution for high-purity chiral purine acyclic nucleosides offering supply chain reliability and cost reduction.
Patent CN112759595B details a novel Pd-catalyzed asymmetric allylation for chiral nucleosides, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.